Table 3.

VTE events per phase and type in the DF/HCC cohort (n = 191).

	DF/HCC Cohort
	Patients evaluated	Patients with VTE (N,%)	Number of Events (N)a
Overall	191	69 (36.1)	82
Induction	191	24 (12.6)	25
Consolidation	170	44 (25.9)	50
Continuation/ Follow-Up	136	7 (5.2)	7
CSVT	69	7 (10.1)	8
PE	69	23 (33.3)	27
Line associated	69	18 (26.1)	20

VTE venous thromboembolism, CSVT cerebral sinus vein thrombosis.

^a11 patients had multiple events: 10 patients had two events, and 1 patient had 4 events.